Ke Hengte, Xing Zhanwen, Zhao Bo, Wang Jinrui, Liu Jibin, Guo Caixin, Yue Xiuli, Liu Shaoqin, Tang Zhiyong, Dai Zhifei
Nanobiotechnology Division, Bio-X Center, State Key Laboratory of Urban Water Resources and Environment, Harbin Institute of Technology, Harbin 150001, People's Republic of China.
Nanotechnology. 2009 Oct 21;20(42):425105. doi: 10.1088/0957-4484/20/42/425105. Epub 2009 Sep 25.
The aim of this paper was to develop a novel bi-mode ultrasound/fluorescent imaging agent through stepwise layer-by-layer deposition of poly(allylamine hydrochloride) (PAH) and CdTe quantum dots (QDs) onto ST68 microbubbles (MBs) produced by sonication of a mixture of surfactants (Span 60 and Tween 80). The experiments using photoluminescence spectroscopy and confocal laser scanning microscopy confirmed that CdTe nanoparticles were successfully adsorbed on the outer surface of the MBs. The static light scattering measurements showed that size distributions of MBs before and after QD deposition met the size requirements for clinical application. The in vitro and in vivo ultrasonography indicated that the QD-modified MBs maintained good contrast enhancement properties as the original MBs. Furthermore, the in vitro ultrasound-targeted microbubble destruction (UTMD) experiment of the QD-MB composites was carried out to validate the ability of MBs to deliver QDs for fluorescent imaging. The results showed that the QD-modified MBs not only maintained the capability of ultrasound imaging, but also could be used as a targeted-drug controlled-release system to deliver the QDs for cell and tissue fluorescent imaging by UTMD. The novel dual-functional imaging agent has potential for a variety of biological and medical applications.
本文的目的是通过将聚(烯丙胺盐酸盐)(PAH)和碲化镉量子点(QDs)逐步逐层沉积到由表面活性剂(Span 60和吐温80)混合物超声处理产生的ST68微泡(MBs)上,开发一种新型的双模式超声/荧光成像剂。使用光致发光光谱和共聚焦激光扫描显微镜进行的实验证实,碲化镉纳米颗粒成功吸附在微泡的外表面。静态光散射测量表明,量子点沉积前后微泡的尺寸分布符合临床应用的尺寸要求。体外和体内超声检查表明,量子点修饰的微泡保持了与原始微泡一样良好的对比增强特性。此外,进行了量子点-微泡复合材料的体外超声靶向微泡破坏(UTMD)实验,以验证微泡递送量子点用于荧光成像的能力。结果表明,量子点修饰的微泡不仅保持了超声成像能力,还可以用作靶向药物控释系统,通过UTMD递送量子点用于细胞和组织荧光成像。这种新型的双功能成像剂在各种生物和医学应用中具有潜力。